Viral Oncology

 An oncolytic virus is a virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by oncolysis, they release new infectious virus particles or virions to help destroy the remaining tumour. Oncolytic viruses are thought not only to cause direct destruction of the tumour cells, but also to stimulate host anti-tumour immune system responses.

The potential of viruses as anti-cancer agents was first realised in the early twentieth century, although coordinated research efforts did not begin until the 1960s. A number of viruses including adenovirus, reovirus, measles, herpes simplex, Newcastle disease virus, and vaccinia have been clinically tested as oncolytic agents. Most current oncolytic viruses are engineered for tumour selectivity, although there are naturally occurring examples such as reovirus and the senecavirus, resulting in clinical trials

 

  • Oncovirus
  • HPV & Other Sexually Transmitted Diseases
  • Cancer Immunotherapy

Related Conference of Viral Oncology

August 26-27, 2020

World Congress on Histopathology & Cytopathology

Kyoto, Japan
September 24-25, 2020

Global Digital Pathology Summit

Paris, France
October 19-20, 2020

World Congress on Pathology and Microbiology

Manila, Philippines
October 19-20, 2020

Global Pathologists Meet

Manila, Philippines
November 25-26, 2020

18th Asia Pacific Pathology Congress

Tokyo, Japan
December 07-08, 2020

7th Annual Meet on Cardiology and Heart diseases

Prague, Czech Republic

Viral Oncology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in